EGRX Eagle Pharmaceuticals, Inc. Accounting Capitalization

Corporate emblem and logo of Eagle Pharmaceuticals Inc. (EGRX)

The Eagle Pharmaceuticals (EGRX) price chart on the GURU.Markets platform illustrates the asset's dynamics, with its value currently 0.25. The business is shielded from global shocks due to its operations within the FDA regulatory framework. Revenue is generated through the production of modernized oncology injections and partnership payments. Efficiency is driven by the recruitment of regulatory experts, who are retained via stock options and a lack of corporate formalism.

Eagle Pharmaceuticals, Inc. (EGRX) - Company Book Value from 07/04/2022 to 10/12/2024

Eagle Pharma - analytical breakdowns and key metrics (EGRX)

- price and consensus price forecast:
Price Performance Chart Eagle Pharmaceuticals|EGRX - Consensus Target
- market capitalization data:
Market Capitalization Eagle Pharmaceuticals Inc.|EGRX - Enterprise Value
- book capitalization data:
Net Assets per Single Share Eagle Pharmaceuticals|EGRX - Company Book Value|Market Value to Book Value eagleus.com|EGRX - Company Total Assets
- debt and liquidity data:
Debt to Capital Eagle Pharmaceuticals|EGRX - Long-Term Debt to Capital|Short-Term Debt to Capital Eagle Pharmaceuticals|EGRX - Company Debts|Debts to Net Assets Eagle Pharmaceuticals Inc.|EGRX - Company Long-Term Liabilities|Amount of Current Liabilities Eagle Pharmaceuticals
Summary company analytics:Eagle Pharmaceuticals
Mass-produced product of Eagle Pharma

When assessing the asset quality of Eagle Pharmaceuticals (EGRX), investors must consider the company's ability to convert the modernization of legacy molecules into a sustainable financial foundation. By analyzing the balance sheet capitalization metric, we measure the difference between all assets and liabilities, which reflects the net equity value and confirms the business's capacity to maintain high-margin cash cow drugs even amidst external market shocks.

Competitors of Eagle Pharmaceuticals (EGRX)

Olema Corp (OLMA) - Accounting Value of Company|Company Net Assets pumabiotechnology.com|greenwichlifesciences.com (GLSI) - Accounting Capitalization|Book Capitalization Zentalis|Company Book Value MGNX|Plus Therapeutics, Inc. (PSTV) - Company Book Value|Accounting Value of Company processapharmaceuticals.com (PCSA)